Observe Medical ASA (STU:OM50) EBIT: €-3.70 Mil (TTM As of Dec. 2025)


STU:OM50 Observe Medical ASA STU:OM50
30 GF Score
Price €0.09
GF Value €0.02
! 5 Warning Signs
View Full Analysis

What is Observe Medical ASA EBIT?

Observe Medical ASA STU:OM50 -3.40% 30 EBIT is €-3.70 Mil as of Dec. 2025. GuruFocus rates STU:OM50 with a GF Score™ of 30/100 and a GF Value™ of €0.02. The stock has 5 warning signs investors should review.

Observe Medical ASA's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €-2.40 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €-3.70 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Observe Medical ASA's annualized ROC % for the quarter that ended in Dec. 2025 was -32.73%. Observe Medical ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -59,925.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Observe Medical ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -23.61%.


Observe Medical ASA  (STU:OM50) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Observe Medical ASA's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-3.658 * ( 1 - 0% )/( (13.491 + 8.859)/ 2 )
=-3.658/11.175
=-32.73 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Observe Medical ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-4.794/( ( (0.011 + max(-3.516, 0)) + (0.005 + max(-2.207, 0)) )/ 2 )
=-4.794/( ( 0.011 + 0.005 )/ 2 )
=-4.794/0.008
=-59,925.00 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.225 + 0.369 + 0) - (2.795 + 0 + 1.315)
=-3.516

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.632 + -0.00099999999999989) - (1.636 + 0 + 1.202)
=-2.207

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Observe Medical ASA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-3.7/15.669
=-23.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Observe Medical ASA EBIT Related Terms


Observe Medical ASA EBIT Historical Data

* Premium members only.

The historical data trend for Observe Medical ASA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Observe Medical ASA EBIT Chart

Observe Medical ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.27 -4.48 -11.16 -4.19 -3.67

Observe Medical ASA Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.63 -2.00 -2.24 -1.30 -2.40

STU:OM50 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Observe Medical ASA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Observe Medical ASA EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Observe Medical ASA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Observe Medical ASA's EV-to-EBIT falls into.


STU:OM50
30GF Score
Observe Medical ASA STU:OM50
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Observe Medical ASA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-3.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-3.70 Mil mean?
Observe Medical ASA (STU:OM50) has a EBIT of €-3.70 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Observe Medical ASA.
Is Observe Medical ASA's EBIT too high?
Observe Medical ASA's current EBIT is €-3.70 Mil. Overall, Observe Medical ASA has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Observe Medical ASA's EBIT compare to ABT and SYK?
Observe Medical ASA's EBIT of €-3.70 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Observe Medical ASA. Observe Medical ASA's current EBIT is €-3.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Observe Medical ASA stock overvalued right now?
Observe Medical ASA (STU:OM50) has a current EBIT of €-3.70 Mil. The stock's GF Value™ is €0.02, compared to a current price of €0.09 — trading 355% above its estimated fair value. The current EBIT is €-3.70 Mil. Observe Medical ASA's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Observe Medical ASA (STU:OM50), the current EBIT is €-3.70 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Observe Medical ASA (STU:OM50) Overvalued in 2026?

Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued. The current stock price of €0.09 is trading 355% above its estimated GF Value™ of €0.02.

Key valuation signals for STU:OM50:

  • EBIT: €-3.70 Mil
  • GF Value™: €0.02 vs. price of €0.09 (355% above fair value)
  • GF Score™: 30/100 with 5 warning signs

No single metric tells the full story. See the STU:OM50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Observe Medical ASA Business Description

Other Exchanges OBSRV:NorwayOM50:Germany
Address Dronning Eufemias gate 16, Oslo, NOR, 0191
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
30GF Score

Get the complete analysis for STU:OM50

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.02
GF Value